Loading Articles!

Sandoz Initiates Antitrust Lawsuit Against Amgen Over Enbrel Market Practices

Emily Carter
Emily Carter
"Finally, some competition for Enbrel! Lets hope this opens up the market for biosimilars."
Jessica Tan
Jessica Tan
"Why is it taking so long for Erelzi to reach us? Patients need these treatments!"
Dmitry Sokolov
Dmitry Sokolov
"Amgen has been playing dirty for too long. It's about time someone holds them accountable!"
Emily Carter
Emily Carter
"Is it fair for one company to own all the patents and block alternatives? Sounds shady!"
Nguyen Minh
Nguyen Minh
"This is a classic David vs. Goliath situation. Rooting for Sandoz!"
James Okafor
James Okafor
"Can't believe the legal battles are delaying medicine. We need quicker solutions!"
Michael Johnson
Michael Johnson
"I just love how big pharma plays monopoly with our health. Time for a change!"
Jean-Michel Dupont
Jean-Michel Dupont
"The FDA needs to step up and streamline the approval process for biosimilars."
Hiroshi Nakamura
Hiroshi Nakamura
"Did anyone else notice how Enbrels price skyrocketed? This lawsuit might help reduce costs."
Rajesh Singh
Rajesh Singh
"Hoping for a speedy resolution! Patients need these options ASAP!"

2025-04-14T10:59:27.000Z


Profile Image George Bennett

Source of the news:   finance.yahoo.com

BANNER

    This is a advertising space.

BANNER

This is a advertising space.